57
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction

, , , , , , , & show all
Pages 7631-7638 | Published online: 14 Aug 2019

References

  • Sano T. Gastric cancer: Asia and the world. Gastric Cancer. 2017;20(Suppl 1):1–2. doi:10.1007/s10120-017-0694-9
  • Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–99. doi:10.3322/caac.2138828094848
  • Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64(12):1881–1888. doi:10.1136/gutjnl-2014-30891525748648
  • Ford JM. Hereditary gastric cancer: an update at 15 years. JAMA Oncol. 2015;1(1):16–18. doi:10.1001/jamaoncol.2014.18726182297
  • Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.0129545714
  • Moehler M, Baltin CT, Ebert M, et al. International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus. Gastric Cancer. 2015;18(3):550–563. doi:10.1007/s10120-014-0403-x25192931
  • Roviello G, Petrioli R, Marano L, et al. Angiogenesis inhibitors in gastric and gastroesophageal junction cancer. Gastric Cancer. 2016;19(1):31–41. doi:10.1007/s10120-015-0537-526329368
  • Fuchs CS, Niedzwiecki D, Mamon HJ, et al. Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: results from CALGB 80101 (Alliance). J Clinl Oncol. 2017;35(32):3671–3677. doi:10.1200/JCO.2017.74.2130
  • Haga Y, Hato S, Ikenaga M, et al. Validation of an assessment tool: estimation of postoperative overall survival for gastric cancer. Eur J Surg Oncol. 2018;44(4):515–523. doi:10.1016/j.ejso.2018.01.00229422249
  • Reddy JP, Hernandez M, Gunther JR, et al. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. Br J Haematol. 2018;180(4):545–549. doi:10.1111/bjh.1505429271057
  • Zhao QT, Yuan Z, Zhang H, et al. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: a meta-analysis including 3,720 patients. Int Cancer. 2016;139(1):164–170. doi:10.1002/ijc.30060
  • Chan AW, Chan SL, Wong GL, et al. Prognostic Nutritional Index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol. 2015;22(13):4138–4148. doi:10.1245/s10434-015-4516-125801356
  • Niwa N, Matsumoto K, Ide H, Nagata H, Oya M. Prognostic value of pretreatment albumin-to-globulin ratio in patients with non-muscle-invasive bladder cancer. Clin Genitourin Cancer. 2018;16(3):e655–e661. doi:10.1016/j.clgc.2017.12.01329366633
  • Shimizu T, Ishizuka M, Suzuki T, et al. The preoperative globulin-to-albumin ratio, a novel inflammation-based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma. J Surg Oncol. 2017;116(8):1166–1175. doi:10.1002/jso.2477228853157
  • Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum. 2015;58(11):1048–1057. doi:10.1097/DCR.000000000000045826445177
  • Mohri T, Mohri Y, Shigemori T, Takeuchi K, Itoh Y, Kato T. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J Surg Oncol. 2016;14(1):170. doi:10.1186/s12957-016-0920-727349744
  • Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nature Rev Cancer. 2013;13(11):759–771. doi:10.1038/nrc361124154716
  • Dehne N, Mora J, Namgaladze D, Weigert A, Brüne B. Cancer cell and macrophage cross-talk in the tumor microenvironment. Curr Opin Pharmacol. 2017;35:12–19. doi:10.1016/j.coph.2017.04.00728538141
  • Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res. 2016;18(1):84. doi:10.1186/s13058-016-0740-227515302
  • Carr BI, Guerra V. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients. Int J Biol Markers. 2017;32(4):e391–e396. doi:10.5301/ijbm.500030028862714
  • Tsai MH, Chuang HC, Lin YT, et al. Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction-a retrospective study. PeerJ. 2018;6:e4490. doi:10.7717/peerj.449029576961
  • Ikeda S, Yoshioka H, Ikeo S, et al. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status. BMC Cancer. 2017;17(1):797. doi:10.1186/s12885-017-3814-329183294
  • Miura K, Hamanaka K, Koizumi T, et al. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: comparative study of normal lung, emphysema, and pulmonary fibrosis. Lung Cancer. 2017;111:88–95. doi:10.1016/j.lungcan.2017.07.00328838406
  • Pfensig C, Dominik A, Borufka L, Hinz M, Stange J, Eggert M. A new application for albumin dialysis in extracorporeal organ support: characterization of a putative interaction between human albumin and proinflammatory cytokines IL-6 and TNFalpha. Artif Organs. 2016;40(4):397–402. doi:10.1111/aor.1255726365493
  • Hirashima K, Watanabe M, Shigaki H, et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49(6):1040–1046. doi:10.1007/s00535-013-0855-523821018
  • Kwag SJ, Kim JG, Kang WK, Lee J-K, Oh S-T. The nutritional risk is a independent factor for postoperative morbidity in surgery for colorectal cancer. Annals Surgi Treat Res. 2014;86(4):206–211. doi:10.4174/astr.2014.86.4.206
  • Geng Y, Qi Q, Sun M, Chen H, Wang P, Chen Z. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer. Eur J surg oncol. 2015;41(11):1508–1514. doi:10.1016/j.ejso.2015.07.02226343824
  • Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. 2013;20(8):2647–2654. doi:10.1245/s10434-013-2926-523463091
  • Wu SJ, Lin YX, Ye H, Li F-Y, Xiong X-Z, Cheng N-S. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy. J Surg Oncol. 2016;114(2):202–210. doi:10.1002/jso.2429727199001
  • Bozkaya Y, Erdem GU, Demirci NS, et al. Prognostic importance of the albumin to globulin ratio in metastatic gastric cancer patients. Curr Med Res Opin. 2019 Feb;35(2):275–282. doi: 10.1080/03007995.2018.1479683. Epub 2018 Jun 20.
  • Neal CP, Cairns V, Jones MJ, et al. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases. Medical Oncol. 2015;32(5):144. doi:10.1007/s12032-015-0590-2
  • Sun X, Liu X, Liu J, et al. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer. Chin J Cancer. 2016;35(1):57. doi:10.1186/s40880-016-0122-227342313